Patents by Inventor John C. M. Stewart

John C. M. Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5859055
    Abstract: Gamma-linolenic acid and/or dihomo-gamma-linolenic acid is used in the preparation of a medicament for inhibiting reocclusion of an artery from which an occlusion or other blockage has been removed, or for preventing occlusion of peripheral or coronary arteries. The medicament may also comprise eicosapentaenoic acid.
    Type: Grant
    Filed: November 14, 1995
    Date of Patent: January 12, 1999
    Assignee: Scotia Holdings PLC
    Inventors: David F. Horrobin, John C. M. Stewart
  • Patent number: 5378732
    Abstract: Gamma-linolenic acid and/or dihomo-gamma-linolenic acid is used in a medicament for reducing the rate of reocclusion of an artery from which an occlusion or other blockage has been removed, or for preventing occlusion of peripheral or coronary arteries. The medicament may also comprise eicosapentaenoic acid.
    Type: Grant
    Filed: November 25, 1992
    Date of Patent: January 3, 1995
    Assignee: Scotia Holdings PLC
    Inventors: David F. Horrobin, John C. M. Stewart
  • Patent number: 5276020
    Abstract: Anti-virals wherein a linoleyl, gamma-linolenyl or other unsaturated long chain fatty acyl group is borne directly on a hydroxy or amino group of the sugar/sugar analogue or heterocyclic moiety of a nucleoside or nucleoside analogue.
    Type: Grant
    Filed: December 14, 1992
    Date of Patent: January 4, 1994
    Assignee: Efamol Holdings plc
    Inventors: David F. Horrobin, John C. M. Stewart, Michael D. Winther
  • Patent number: 5216142
    Abstract: Anti-virals wherein a linoleyl, gamma-linolenyl or other unsaturated long chain fatty acyl group is borne directly on a hydroxy or amino group of the sugar/sugar analogue or heterocyclic moiety of a nucleoside or nucleoside analogue.
    Type: Grant
    Filed: April 10, 1990
    Date of Patent: June 1, 1993
    Assignee: Efamol Holdings plc
    Inventors: David F. Horrobin, John C. M. Stewart, Michael D. Winther
  • Patent number: 5116871
    Abstract: The use of one or more of the 6-desaturated or higher EFAs of each of the n-6 and n-3 series for the manufacture of a medicament for use in the treatment of post-viral fatigue syndrome (otherwise known as myalgic encephalomyelitis (ME)).
    Type: Grant
    Filed: August 24, 1989
    Date of Patent: May 26, 1992
    Assignee: Efamol Holdings PLC
    Inventors: David F. Horrobin, John C. M. Stewart
  • Patent number: 4997657
    Abstract: A composition, particularly an oral composition, for improving the smoothness of the skin, wherein GLA or DGLA or both as such or in the form of physiologically acceptable and equivalent derivatives are brought into administrable form with a carrier or diluent.
    Type: Grant
    Filed: March 9, 1989
    Date of Patent: March 5, 1991
    Assignee: Efamol Holdings, plc
    Inventors: David F. Horrobin, John C. M. Stewart